4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-007880
SVP & Chief Accounting Officer sold 16,119 shares at $42.16 ($679,577)
- SVP & Chief Accounting Officer acquired 16,119 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2019-02-04 | Option exercise | +16,119 | $10.69 | $172,312 | 184,318 | D: show line 1 in the form |
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2019-02-04 | Sale | −16,119 | $42.16 | $679,577 | 168,199 | D: show line 2 in the form |
| Open-market sales · 16,119 sh · avg $42.16 · $679,577 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomsen Jillian B. SVP & Chief Accounting Officer | 2019-02-04 | Option exercise · Stock Option | −16,119 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…